Fig. 1.
Physiological concentrations of PGE2-induced HPK1 kinase activity.
HA-HPK1 was immunoprecipitated from lysates derived from Jurkat T cells transfected with HA-HPK1. Cells were exposed to varying concentrations of PGE2 for 2 minutes at 37°C prior to lysis and immunoprecipitation. In vitro immune complex HPK1 kinase assays (IVK) were performed in the presence of exogenous substrate, 5 μg histone H2A. (A) 32P-incorporated histone H2A. (B)32P-incorporated auto-transphosphorylated HA-HPK1. (C) Western blot of immunoprecipitated HPK1 from panel B, using the anti-HPK1 no. 7 antibody. (D) In vitro immune complex HPK1 kinase assays were performed on lysates of PGE2-stimulated (10 nM) transfectants expressing wild-type or a catalytically inactive mutant (K46E) of HPK1. The autoradiographic bands depict32P-incorporated histone H2A. (E)32P-incorporated autophosphorylated/transphosphorylated wild-type and (K46E) mutant HPK1. (F) Western blot of immunoprecipitated HPK1 from panel E, using the anti-HPK1 no. 7 antibody. (G) In vitro immune complex kinase assays performed with endogenous HPK1 immunoprecipitated from nontreated cells or from cells treated with 10 nM PGE2. (H) Western blot of immunoprecipitated HPK1 from panel G, using the anti-HPK1 no. 7 antibody. Lane numbers are indicated at the bottom of all lanes. Data in all figures are representative of at least 3 independent experiments.